Genelux Corp (GNLX)
3.60
-0.04
(-1.10%)
USD |
NASDAQ |
May 16, 16:00
3.60
0.00 (0.00%)
After-Hours: 20:00
Genelux Price: 3.60 for May 16, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
May 16, 2024 | 3.62 | 3.66 | 3.50 | 3.60 | 63653.00 |
May 15, 2024 | 3.58 | 3.90 | 3.58 | 3.64 | 93538.00 |
May 14, 2024 | 3.71 | 3.96 | 3.34 | 3.58 | 189693.0 |
May 13, 2024 | 3.89 | 3.895 | 3.55 | 3.61 | 73270.00 |
May 10, 2024 | 3.96 | 4.00 | 3.60 | 3.83 | 106783.0 |
May 09, 2024 | 3.78 | 4.025 | 3.67 | 4.02 | 101378.0 |
May 08, 2024 | 3.67 | 3.97 | 3.65 | 3.79 | 113101.0 |
May 07, 2024 | 3.89 | 3.905 | 3.555 | 3.65 | 88594.00 |
May 06, 2024 | 3.95 | 4.11 | 3.78 | 3.84 | 152759.0 |
May 03, 2024 | 3.59 | 3.88 | 3.39 | 3.83 | 124408.0 |
May 02, 2024 | 3.39 | 3.49 | 3.14 | 3.48 | 120632.0 |
May 01, 2024 | 3.13 | 3.35 | 3.13 | 3.28 | 160323.0 |
Apr 30, 2024 | 3.19 | 3.19 | 3.06 | 3.11 | 107636.0 |
Apr 29, 2024 | 3.45 | 3.600 | 3.16 | 3.17 | 108816.0 |
Apr 26, 2024 | 3.33 | 3.42 | 3.22 | 3.40 | 85044.00 |
Apr 25, 2024 | 3.39 | 3.41 | 3.07 | 3.32 | 147726.0 |
Apr 24, 2024 | 3.50 | 3.635 | 3.26 | 3.45 | 137230.0 |
Apr 23, 2024 | 3.38 | 3.59 | 3.38 | 3.48 | 147731.0 |
Apr 22, 2024 | 4.19 | 4.22 | 3.33 | 3.35 | 262781.0 |
Apr 19, 2024 | 3.87 | 4.19 | 3.755 | 4.13 | 129908.0 |
Apr 18, 2024 | 3.68 | 3.98 | 3.63 | 3.86 | 107810.0 |
Apr 17, 2024 | 3.54 | 3.80 | 3.50 | 3.615 | 167780.0 |
Apr 16, 2024 | 3.81 | 4.07 | 3.42 | 3.52 | 291984.0 |
Apr 15, 2024 | 4.16 | 4.16 | 3.76 | 3.80 | 130133.0 |
Apr 12, 2024 | 4.26 | 4.29 | 4.025 | 4.12 | 83674.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
3.11
Minimum
Apr 30 2024
38.00
Maximum
Jun 21 2023
17.53
Average
16.90
Median
Mar 01 2023
Price Benchmarks
CEL-SCI Corp | 1.40 |
AIM ImmunoTech Inc | 0.39 |
IGC Pharma Inc | 0.5958 |
NovaBay Pharmaceuticals Inc | 0.12 |
Protalix BioTherapeutics Inc | 1.17 |
Price Related Metrics
Price to Book Value | 6.443 |
Earnings Yield | -26.94% |
Market Cap | 97.19M |